2-26519015-T-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_194248.3(OTOF):​c.322A>G​(p.Ile108Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000579 in 1,606,180 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000056 ( 1 hom. )

Consequence

OTOF
NM_194248.3 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 3.02

Publications

0 publications found
Variant links:
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
OTOF Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08672848).
BP6
Variant 2-26519015-T-C is Benign according to our data. Variant chr2-26519015-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 179879.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOFNM_194248.3 linkc.322A>G p.Ile108Val missense_variant Exon 4 of 47 ENST00000272371.7 NP_919224.1
OTOFNM_001287489.2 linkc.322A>G p.Ile108Val missense_variant Exon 4 of 46 NP_001274418.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOFENST00000272371.7 linkc.322A>G p.Ile108Val missense_variant Exon 4 of 47 1 NM_194248.3 ENSP00000272371.2
OTOFENST00000403946.7 linkc.322A>G p.Ile108Val missense_variant Exon 4 of 46 5 ENSP00000385255.3

Frequencies

GnomAD3 genomes
AF:
0.0000722
AC:
11
AN:
152252
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000108
AC:
26
AN:
241140
AF XY:
0.000169
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000274
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000462
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.0000564
AC:
82
AN:
1453810
Hom.:
1
Cov.:
30
AF XY:
0.0000830
AC XY:
60
AN XY:
722680
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33398
American (AMR)
AF:
0.00
AC:
0
AN:
44218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25814
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39668
South Asian (SAS)
AF:
0.000635
AC:
54
AN:
85044
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53086
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1106738
Other (OTH)
AF:
0.0000832
AC:
5
AN:
60088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152370
Hom.:
0
Cov.:
34
AF XY:
0.000107
AC XY:
8
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41594
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.000124
AC:
15
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 04, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Ile108Val variant in OTOF has not been previously reported in individuals wi th hearing loss and was absent from large population studies. Computational pred iction tools and conservation analysis do not provide strong support for or agai nst an impact to the protein. In summary, the clinical significance of the Ile10 8Val variant is uncertain. -

Inborn genetic diseases Uncertain:1
Mar 07, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.322A>G (p.I108V) alteration is located in exon 4 (coding exon 4) of the OTOF gene. This alteration results from a A to G substitution at nucleotide position 322, causing the isoleucine (I) at amino acid position 108 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Mar 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.052
T;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.15
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.88
D;D
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.087
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.81
L;L
PhyloP100
3.0
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.45
N;N
REVEL
Benign
0.10
Sift
Benign
0.16
T;T
Sift4G
Benign
0.38
T;T
Polyphen
0.063
B;.
Vest4
0.47
MutPred
0.42
Loss of ubiquitination at K109 (P = 0.0604);Loss of ubiquitination at K109 (P = 0.0604);
MVP
0.80
MPC
0.13
ClinPred
0.12
T
GERP RS
2.7
Varity_R
0.092
gMVP
0.20
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727505189; hg19: chr2-26741883; API